Thermo Fisher Completes $2.53 Billion Common Stock Offering

Download IconDownload Print IconPrint

Thermo Fisher Completes $2.53 Billion Common Stock Offering

Attorney News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
Our team provides incisive guidance on all facets of futures and derivatives transactions, regulatory compliance and enforcement.
A deep and diverse practice focused on maximizing tax efficiencies and minimizing tax risks for clients nationally and internationally.

A team of WilmerHale transactional lawyers represented Thermo Fisher Scientific Inc. in its recently completed $2.53 billion underwritten public offering of its common stock made in connection with the forward sale agreements described below. J.P. Morgan and Barclays acted as joint book-running managers and as representatives of the underwriters for the offering. BofA Merrill Lynch acted as book-running manager for the offering. Thermo Fisher intends to use the proceeds from the settlement of the forward sale agreements to fund a portion of its recent acquisition of Life Technologies Corporation.

The forward sale agreements, entered into with affiliates and forward counterparties of J.P. Morgan and Barclays borrowed stock from third parties for sale in the offering. This enabled Thermo Fisher to raise equity based on its current stock price, but delay dilution of current stock owners' holdings and earnings per share until they settle the forward sale agreements.

To learn more about the deal, read Thermo Fisher’s press release.

The WilmerHale team representing Thermo Fisher includes Partners David Redlick and Erika Robinson; Senior Associates Todd Anderman and Jared DeMatteis; Associates Jordan Schwartz and Kevin Bale, with Partner Julie Hogan Rodgers on tax matters. The derivatives team included Partners Jeannette Boot and Dino Wu; and Associate Ellie Guadiana.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel